Structural basis of Lewis(b) antigen binding by the Helicobacter pylori adhesin BabA by Hage, Naim et al.
R E S EARCH ART I C L EBACTER IOLOGY1School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD,
UK. 2Discovery Sciences, Innovative Medicines and Early Development, AstraZeneca
R&D, Alderley Park, Cheshire SK10 4TG, UK. 3Discovery Sciences, Innovative Medicines
and Early Development, AstraZeneca R&D, Darwin Building, 310 Cambridge Science
Park, Milton Road, Cambridge CB4 0WG, UK. 4Pharmaceutical Development, AstraZeneca
R&D, Charter Way, Macclesfield, Cheshire SK10 2NA, UK.
*These authors contributed equally to this work.
†Corresponding author. E-mail: tina.howard@astrazeneca.com (T.H.); franco.falcone@
nottingham.ac.uk (F.H.F.)
Hage et al. Sci. Adv. 2015;1:e1500315 14 August 20152015 © The Authors, some rights reserved;
exclusive licensee American Association for
the Advancement of Science. Distributed
under a Creative Commons Attribution
License 4.0 (CC BY). 10.1126/sciadv.1500315Structural basis of Lewisb antigen binding by the
Helicobacter pylori adhesin BabA
Naim Hage,1* Tina Howard,2*† Chris Phillips,3 Claire Brassington,2 Ross Overman,2
Judit Debreczeni,3 Paul Gellert,4 Snow Stolnik,1 G. Sebastiaan Winkler,1 Franco H. Falcone1†Helicobacter pylori is a leading cause of peptic ulceration and gastric cancer worldwide. To achieve colonization of
the stomach, this Gram-negative bacterium adheres to Lewisb (Leb) antigens in the gastric mucosa using its outer
membrane protein BabA. Structural information for BabA has been elusive, and thus, itsmolecularmechanism for
recognizing Leb antigens remains unknown. We present the crystal structure of the extracellular domain of BabA,
from H. pylori strain J99, in the absence and presence of Leb at 2.0- and 2.1-Å resolutions, respectively. BabA is a
predominantly a-helical molecule with amarkedly kinked tertiary structure containing a single, shallow Leb bind-
ing site at its tip within a b-strand motif. No conformational change occurs in BabA upon binding of Leb, which is
characterized by low affinity under acidic [KD (dissociation constant) of ~227 mM] and neutral (KD of ~252 mM)
conditions. Binding is mediated by a network of hydrogen bonds between Leb Fuc1, GlcNAc3, Fuc4, and Gal5
residues and a total of eight BabA amino acids (C189, G191, N194, N206, D233, S234, S244, and T246) through
both carbonyl backbone and side-chain interactions. The structural model was validated through the generation
of two BabA variants containing N206A and combined D233A/S244A substitutions, which result in a reduction
and complete loss of binding affinity to Leb, respectively. Knowledge of the molecular basis of Leb recognition by
BabA provides a platform for the development of therapeutics targeted at inhibiting H. pylori adherence to the
gastric mucosa.INTRODUCTION
Helicobacter pylori is one of the most common causative agents of
bacterial infections in the world with more than one-half of the global
population affected (1). This microaerophilic, Gram-negative bacteri-
um colonizes the human gastric mucosa and is a strong risk factor for
the development of peptic ulceration, gastric adenocarcinoma, and
gastric mucosa–associated lymphoid tissue (MALT) lymphoma. In-
fection byH. pylori can persist in the harsh conditions of the stomach
for decades (2, 3). This is achieved through unique evolutionary adapt-
ations, including the use of a variety of outer membrane proteins to
adhere to glycan moieties on the gastric epithelium (4, 5). Through
this mechanism, clearance from the stomach during mucus turnover
is evaded, and local colonization is sustained (6).
The blood group antigen–binding adhesin (BabA) is one of the
best-characterized adhesion proteins of the bacterium. It contains two
domains: an N-terminal extracellular host-binding domain (7–9) and
a C-terminal outer membrane–spanning domain predicted to form a
b-barrel structure similar to that of known porins (10). Most disease-
causing strains express this adhesin, and its presence on the bacterium
correlates with enhanced colonization and virulence (11–14). BabA
mediates H. pylori attachment by binding to fucosylated histo-blood
group antigens found on gastric epithelial cells and mucin (fig. S1).
Themost studied of these interactions is between BabA and the Lewisb
(Leb) antigen. This difucosylated oligosaccharide is abundantly ex-pressed by the healthy gastricmucosa ofmost individuals in theWest-
ern population with the O phenotype, who are also the most
susceptible to peptic ulcer disease (15, 16).However, the BabAbinding
site responsible for Leb attachment has remained elusive.
The lack of structural information for BabA hinders the develop-
ment of strategies to treat antibiotic-resistant infections through the
inhibition of H. pylori attachment to the gastric mucosa. The poten-
tial of this approach has already been demonstrated for uropatho-
genic E. coli, where inhibition of its FimH adhesin can successfully
treat and prevent infection (17, 18). Here, we investigated the molec-
ular interactions that mediate BabA binding to Leb antigens by x-ray
crystallography. We present the crystal structure of the extracellular
domain of BabA in the absence and presence of Leb at 2.0- and 2.1-Å
resolutions, respectively.RESULTS
Crystal structure of BabA
We first determined the crystal structure of the N-terminal extra-
cellular domain of BabA, from strain J99 (19), to 2.0-Å resolution
(table S1). BabA contains two predominantly a-helical regions—a
handle and head region, and a third b-sheet motif located on top
of the head region. We term this b-strand unit the crown (Fig. 1A).
The handle region, containing both the N and C termini of the
extracellular domain, forms an a+b unit. The N-terminal helix (a-N)
forms a two-helix antiparallel coiled-coil bundle with a C-terminal
helix (a-C1) of similar approximate length. This C-terminal helix is
followed by a two-strand antiparallel b-sheet (b-C) before ending with
a short a-helix (a-C2), which packs against a-N in an antiparallel ori-
entation. In the native BabA protein, the highly conserved putative b-
barrel transmembrane domain succeeds thea-C2 helix (fig. S2). The core
of the head region is composed of a four-helix antiparallel coiled-coil1 of 9
R E S EARCH ART I C L Ebundle, similar to a tetratricopeptide repeat motif (a-1 to a-4), at a near
perpendicular angle to the handle region creating the markedly kinked
tertiary structure. The connecting features between these four helices
are (i) a loop containing a shorta-helix (followed by a disordered region
of seven amino acids) between a-3 and a-4; (ii) a 20–amino acid loop
between a-2 and a-3; and (iii) a ~200–amino acid segment (including
a disordered region of 8 amino acids) between the a-1 and a-2 helices.
This connecting segment, which extends out of the core of the head
region, contains a small b-sheet (b-1), a pair of interacting a-helices
(a-1a and a-1b), and the crown—a four-strand antiparallel b-sheet at
the highest tip of the protein (b-2).
BabA belongs to the Helicobacter outer membrane porins (Hop)
family, fromwhich the crystal structure of the functionally related sialic
acid–binding adhesin (SabA), from H. pylori strain 26695, has been
determined (20). The extracellular domain of SabA 26695, which shares
only 26% amino acid sequence identity with that of BabA J99 (fig. S3),
was identified as the single most related structure in the Protein Data
Bank (PDB) database [Fig. 1B; root mean square deviation (RMSD) =
3.7 Å for all Ca atoms (21)]. Superimposition of BabA and SabA shows
that the a-1a helix is a common characteristic. This feature has been
suggested to form part of the glycan binding cavity of SabA, which rec-
ognizes sialyl-Lewisx (SLex) antigens found on cancerous and inflamed
gastric tissue (20). Whereas both proteins share highly similar three-
dimensional folds, the four-strand antiparallel b-sheet crown of BabA is
altogether absent in SabA.
No DNA or protein sequences with similarity to the crown in
H. pylori or any other organism were identified in NCBI (National
Center for Biotechnology Information) nucleotide sequence and
nonredundant protein sequence databases.
Crystal structure of BabA in complex with Leb
Toobtain structural insight into Leb binding,we solved the crystal struc-
ture of BabA in complex with a hexasaccharide form of the Leb antigen
to 2.1-Å resolution (table S1). This oligosaccharide contains two fucoseHage et al. Sci. Adv. 2015;1:e1500315 14 August 2015residues (Fuc1 and Fuc4), two galactose residues (Gal2 andGal5), anN-
acetylglucosamine residue (GlcNAc3), and a glucose residue (Glc6).
Structure determination revealed a single, shallow binding site at the
tip of the BabA crown (Fig. 2). All Leb residues were visible in the elec-
tron density map except the terminal Glc6 residue, which is con-
sequently not modeled (Fig. 2A). A comparison of the BabA crystal
structure in the absence or presence of Leb indicated that no conformational-N 
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Fig. 1. Comparison of the BabA and SabA extracellular domain crystal structures. (A) Crystal structure of the BabA extracellular domain. Indicated
are the handle (blue) and head regions (darkmagenta) and the crown b-strand unit (gold). The four disulfide bridges are represented as green sticks. (B)
Superimposition of the extracellular domains of BabA and SabA (gray).GlcNAc3 
Gal5 
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Fig. 2. The Leb binding site of BabA. (A) Leb binds to BabA at one edge
of the crown. The electron density map around Leb (2Fo − Fc map, con-
toured at 2.0s) in complex with BabA is shown. (B) An electrostatic surface
representation shows Leb binding to a shallow, solvent-exposed pocket
at the tip of BabA containing charged and neutral patches. Fucose, galac-
tose, and N-acetylglucosamine residues are colored orange, yellow, and
blue, respectively.2 of 9
R E S EARCH ART I C L Echange occurred upon sugar binding [fig. S4; RMSD = 0.25Å for all Ca
atoms (22)].
The crystallographic model indicated that binding is mediated by
a network of hydrogen bonds between Leb Fuc1, GlcNAc3, Fuc4, and
Gal5 residues and a total of eight BabA amino acids. Fuc1 forms hy-
drogen bonds with the carbonyl backbone groups of C189, G191, and
N194, and the hydroxyl group of the T246 side chain (Fig. 3A). Fuc4
interacts with the hydroxyl group of the N206 side chain through a
water-mediated hydrogen bond (Fig. 3B). TheGlcNAc3 residue forms
two hydrogen bonds with the carboxyl and hydroxyl side-chain groups
of D233 and S244, respectively (Fig. 3C). Last, Gal5 forms hydrogen
bonds with both the S244 carbonyl backbone and the hydroxyl side-
chain group. It also interacts with both the carboxyl group of the D233
side chain and the hydroxyl group of the S234 side chain throughwater-
mediated hydrogen bonds (Fig. 3D). No interactions were observed be-
tween Gal2 and BabA.
Alignment of BabA J99, used in this study, with BabA from 21H.
pylori strains reported to bind Leb glycoconjugates (23–25) revealed
that the amino acids identified in mediating Leb binding in our struc-Hage et al. Sci. Adv. 2015;1:e1500315 14 August 2015tural model are highly conserved with the exception of N206 (Fig. 4A).
N206 is found within a region (residues 198 to 207 in BabA J99) with
low amino acid conservation across the Leb binding strains. We refer to
this segment, which connects two antiparallel b-strands in the BabA J99
crown, as the hypervariable crown loop (Fig. 4B).
Analysis of BabA:Leb binding
To further characterize the molecular interactions between BabA and
Leb, we used isothermal titration calorimetry (ITC) to study binding
at acidic and neutral pH (Fig. 5A and table S2). In agreement with
the proposed model, binding was found to be a single-site interaction
(N of ~0.91 and ~1.07 at pH 4.5 and 7.4, respectively). The thermo-
dynamic parameters of the interaction indicate that binding is driven
by noncovalent, that is, enthalpic contributions (DH of ~−12.2 and
~−10.9 kcal/mol at pH 4.5 and 7.4, respectively) rather than hydro-
phobic, that is, entropic contributions (−TDS of ~7.2 and ~6.0 kcal/mol at
pH 4.5 and 7.4, respectively). Binding between BabA and Leb molecules
was observed to be a low-affinity interaction [KD (dissociation constant)
of ~227 and ~252 mM at pH 4.5 and 7.4, respectively]. There are noA
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B
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D
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D233 S234 
S244 
Fig. 3. Interactions between BabA amino acids and Leb residues. (A) Fuc1 forms hydrogen bonds with the carbonyl backbone of C189, G191, and
N194 and the side chain of T246. (B) Fuc4 forms a water-mediated hydrogen bond with the N206 side chain. (C) GlcNAc3 forms hydrogen bonds with
the D233 and S244 side chains. (D) Gal5 forms hydrogen bonds with the carbonyl backbone and side chain of S244. Gal5 also forms hydrogen bonds
with awatermolecule structured by the side chains of D233 and S234. Fucose, galactose, andN-acetylglucosamine residues are colored orange, yellow,
and blue, respectively. Hydrogen bonds are represented by dotted black lines.3 of 9
R E S EARCH ART I C L Esignificant differences (P > 0.05) between the thermodynamic parameters
and dissociation constants of BabA:Leb binding at acidic and neutral pH.
To assess the significance of the observed interaction between the
hypervariable crown loop and the Leb Fuc4 residue, we generated and
purified BabA with an N206A amino acid substitution. N206 was ob-
served to form a single water-mediated hydrogen bond with Fuc4
through its polar side chain. In support of the structural model, we
found that the BabA N206A variant had a lower affinity for Leb (KD
of ~582 mM) (Fig. 5B). To assess the significance of the observed inter-
actions between highly conserved amino acids in the crown and the Leb
GlcNAc3 andGal5 residues, we generated and purified BabAwith com-Hage et al. Sci. Adv. 2015;1:e1500315 14 August 2015binedD233A and S244A amino acid substitutions. D233 and S244 both
formed direct and water-mediated hydrogen bonds with GlcNAc3 and
Gal5 through their polar side chains. In further support of our model,
this BabA variant showed no detectable affinity for Leb (Fig. 5C). None
of the aforementioned amino acid substitutions caused a change in the
global structure ofBabAasdeterminedbycircular dichroismspectroscopy
and differential scanning fluorimetry (fig. S5).
Binding of BabA to related histo-blood group antigens
To investigate the relative importance of the Leb sugar residues observed
to interact with the crown, we studied the binding of BabA to a numberGlcNAc3 
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V T Y T Y T C SGEGN T NC S P SV T GA - - - - - - - N SQ SNGSGT K T QT I D GK T V T T T I S SK V VD SRA SGN T LGV SY T E I T NQ L S
VK Y T Y T C SGEGNNNCN P S L L G I A - - - - - DD KQND GSV T K T QT I D GKQV ET S I S SK V VD SKA S SN T T GV SY T E I T NQ L N
VK YN Y T C SGEGNNNC SQ EA T GV - - - - - - - NDQNGGS I T K T QT I D GK T V T TM I S SK V VN ST A PGN T SGV SY T E I T NQ L N
V T Y SY T C SGEGN SNC SKKA T GV - - - - - - - E I QNGGSK T T T QT I D GKQV T T T I S SK V VD SGA EGN T SGV SY T E I T NQ L N
V T Y T Y T C SGEGNNNC SK - - - EV T G I - - - - I DQNGGNK T ET K T I D GK T V T T T I S SK V VD ST A SGN I RH V SY T E I T NK LD
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V T Y SY T C SGEGN T NCN P S L F G I T GT I NNGD GRNGGSV T K T QT I D GK T V T T T I S SK V VD SGAAGN T SGV SY T E I T NQ L N
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Hypervariable crown loop 
A
Fig. 4. Conservation of the Leb binding site of BabA. (A) Sequence alignment of the crown (residues 183 to 253) from BabA J99 with 21 H. pylori
strains shown to bind Leb glycoconjugates. Amino acids involved in hydrogen bond formation to each Leb residue are indicated. (B) The crown b-strand
unit is well conserved (gold) across the analyzed strains with the exception of the hypervariable crown loop (residues 198 to 207; gray). Fucose, ga-
lactose, and N-acetylglucosamine residues are colored orange, yellow, and blue, respectively. Hydrogen bonds are represented by dotted black lines.4 of 9
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(Table 1 and table S3). BabA bound with lower affinity (KD ~617 mM)
to the H-1 antigen, which lacks only the Leb Fuc4 residue that forms a
single water-mediated hydrogen bond with N206. No binding was ob-
served between BabA and the Lewisa (Lea) antigen, which lacks the Leb
Fuc1 residue that forms direct hydrogen bonds with C189, G191, N194,
and T246. Furthermore, no binding was observed between BabA and
the more distantly related Lewisy (Ley) antigen and H-2 antigen. Al-
though Ley and H-2 contain the same residues that were observed in
our structural model to bind BabA as Leb and H-1, respectively, they
differ by having a Galb1-4GlcNAc glycosidic linkage. Finally, no
binding was observed between BabA and SLex. This glycan lacks the
Leb Fuc1 residue and contains a terminal N-acetylneuraminic acid
residue adjoined to a Galb1-4GlcNAc core. Histo-blood group antigens
with Galb1-3GlcNAc and Galb1-4GlcNAc cores markedly differ in
their conformational orientation (fig. S6).DISCUSSION
Here, we identified the molecular interactions involved in BabA-
mediated H. pylori attachment to Leb antigens. This was achieved
by solving the crystal structure of the extracellular domain of BabA,
from H. pylori strain J99, in the absence and presence of Leb. Upon
comparison of the crystal structure of BabA to that of the functionally
related SabA molecule, their striking similarity is immediately appar-
ent. This can be considered to be an unexpected finding, given their
low amino acid sequence identity, suggesting that their similar three-
dimensional folds may be of functional significance. However, an in-
depth analysis and understanding of the H. pylori outer leaflet isHage et al. Sci. Adv. 2015;1:e1500315 14 August 2015needed to aid the functional contextualization and rationalization of
these adhesin structures. SabA does not contain the crown b-sheet
motif of BabA, which we show has its Leb binding site. This structural
difference explains previous reports of the lack of affinity for SabA to
Leb (20). In line with previous studies, we also show that BabA has no
affinity for SLex antigens, which are conversely recognized by SabA
(26). Although a putative glycan binding pocket in SabA has been sug-
gested, crystallographic insight into its structural basis for glycan rec-
ognition is needed to understand the differences that distinguish
binding of SLex antigens between these two adhesins.
The Leb binding interaction takes place in BabA at the edge of its
crown region within a solvent-exposed binding site. The binding
pocket is of a shallow topology, which is typically observed in carbo-
hydrate binding proteins and is known to result in few ligand con-
tacts (27). As a result, bacterial lectins, including SabA, typically display
low glycan binding affinity (20, 28). Low BabA:Leb binding affinity
was similarly found in our study and was additionally observed to
be unaffected by acidic or neutral pH. This characteristic of BabA:
Leb binding may aid H. pylori colonization because these conditions
are representative of the pH gradient found across the gastric mucus
layer (29, 30). Indeed, previous studies have demonstrated thatH. pylori
attachment to gastric mucin under neutral conditions (the pH of the
deep gastric juxtamucosal layer) is mediated by the BabA:Leb interac-
tion (31–33). However, it must be noted that any potential effects of
the membrane-spanning domain of BabA on Leb binding affinity are
not captured by this study. Furthermore, the multitude of BabA:Leb
interactions that occur between H. pylori and epithelium- or mucin-
associated Leb antigens would exponentially increase the binding af-
finity of a single bacterium during colonization. This effect of avidity
on BabA:Leb has been demonstrated inH. pylori J99, which binds LebKD = 252 ± 15 µM 
N = 1.07 ± 0.03 
H = −10.9 ± 0.5 kcal/mol  
−T S = 6.0 ± 0.5 kcal/mol 
A
Wild type 
B
KD = 582 ± 14 µM 
N = 1.03 ± 0.05 
H = −11.8 ± 0.7 kcal/mol 
−T S = 7.4 ± 0.7 kcal/mol 
N206A 
No binding detected 
C
D233A/S244A 
Fig. 5. Binding affinity of wild-type and variant BabA proteins to Leb. (A and B) Calorimetric response (top) and binding isotherm (bottom) of (A)
wild-type BabA titratedwith Leb and (B) the BabAN206A variant titratedwith Leb. The continuous line in both lower panels represents the least-squares
fit of the data to a single-site binding model. The reported thermodynamic parameters are the average (±SEM) of three independent experiments.
(C) No calorimetric response (top) or binding isotherm (bottom) was obtained by titrating BabA containing D233A/S244A substitutions with Leb. All
calorimetric titrations were performed at pH 7.4.5 of 9
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higher affinity [KA (association constant) of ~4 × 10
11 M−1] (24).
Our structural model revealed that BabA J99 uses eight amino
acids to bind to Leb. These amino acids are highly conserved with
the exception of N206, which interacts with Leb Fuc4 and is located
within the hypervariable crown loop. The disparity in sequence iden-
tity and length observed in the hypervariable crown loopmay result in
modified secondary structure folds in otherH. pylori strains and there-
by affect the presentation of functional groups capable of interacting
with Leb Fuc4 or other residues. Thus, we speculate that the variability
in this segment may be responsible, at least in part, for the differences
seen in the affinity of H. pylori strains toward Leb antigens (24). In-
deed, the interaction between N206 and Fuc4 did have an effect on
determining the binding affinity of BabA:Leb in this study. We found
that an alanine point substitution at position 206 resulted in a ~2.3-fold
reduction in binding affinity. Furthermore, analysis of the binding in-
teraction between BabA and the H-1 antigen, the other type 1 histo-
blood group antigen known to act as a receptor for BabA in individualsHage et al. Sci. Adv. 2015;1:e1500315 14 August 2015with the blood group O phenotype (24), supported this finding. H-1
lacks only the Fuc4 residue of Leb and binds to BabA with ~2.4-fold
lower affinity than Leb. Thus, our data suggest that the interaction be-
tween the BabA crown and Leb Fuc4 can play a substantive role in de-
termining binding affinity.
Intriguingly, no DNA or protein sequences with similarity to the
BabA crown were identified inH. pylori or any other organism. In this
light, the crown can be considered unique to BabA to enable attach-
ment ofH. pylori to specific histo-blood group antigens in the human
gastric mucosa. This is achieved through the network of hydrogen
bonds presented because our data show that partial modifications of
these BabA:Leb interactions result in a loss of recognition. As observed
through the analysis of the BabA:Lea interaction, the absence of only
the Fuc1 residue from Leb results in a complete loss of binding. This
occurs despite possible interactions between the crown and the other
sugar residues found in Leb. However, BabA contacts with Fuc1, though
necessary, are not sufficient to confer glycan recognition. Combined al-
anine point substitutions to BabA at D233 and S244, which form direct
and water-mediated hydrogen bonds through their side chains to
GlcNAc3 and Gal5, also result in a complete loss of binding to Leb. This
occurs despite possible interactions between the crown and Fuc1, and
also Fuc4. Thus, we conclude that no single sugar residue is responsible
for Leb recognition by BabA. Rather, it is the network of hydrogen
bonds tomultiple residues that forms the basis ofmolecular recognition.
Consequently, it is no surprise that BabA does not bind to the distantly
related Ley and H-2 antigens because they have completely different
three-dimensional conformations. In most of the Western population,
Lea, Ley, and H-2 antigens are not found in the gastric mucus layer, and
it is known that they do not act as receptors for H. pylori (6, 8, 34).
The structural model presented in this study explains the basis of
BabA-mediated H. pylori attachment to Leb antigens. The recognition
of H-1 antigens, which act as host receptors for BabA in blood group O
individuals, is similarly rationalized through this work. However, fur-
ther investigation is needed to understand the molecular basis
underlying the contrasting differences exhibited by various H. pylori
strains in the recognition of the different histo-blood group antigens
that act as host receptors for BabA in blood group A, B, and O individ-
uals (24). A full comprehension of the molecular interactions required
for adhesion is a promising lead for the development of new strategies
for the treatment of H. pylori infections.METHODS
Study design
The objective of this study was to identify the molecular interactions that
mediate the binding of BabA to Leb antigens. To achieve this, we used
x-ray crystallography to study the interactions between BabA and Leb.
The BabAmolecule used in this study was the extracellular domain of
BabA fromH. pylori J99 [a strain that has been shown to bind Leb anti-
gens (24)] recombinantly expressed in the periplasmic space of E. coli.
A commercially available hexasaccharide form of Leb was used in this
study. A variety of established biophysical, biochemical, and spectro-
scopic techniques were used to probe and validate the structural model.
Cloning, expression, and purification of BabA proteins
Agene fragment encoding the predictedN-terminal extracellular domain
(amino acids 1 to 527) of mature BabA was amplified fromH. pylori J99Table 1. Binding affinity of BabA to various histo-blood group antigens.
Glycan symbolic representations can be interpreted with the following key:
fucose (Fuc, ), galactose (Gal, ), N-acetylglucosamine (GlcNAc, ), glu-
cose (Glc, ), and N-acetylneuraminic acid (Neu5Ac, ). Binding affinity
was determined through calorimetric titrations performed at pH 7.4.
BabA:histo-blood group antigen 
binding affinity
Glycan Symbolic 
Representation
Leb antigen hexasaccharide
KD ~252 µM
H-1 antigen pentasaccharide
KD ~617 µM
Lea antigen pentasaccharide
No binding detected
Ley antigen pentasaccharide
No binding detected
H-2 antigen tetrasaccharide
No binding detected
SLex antigen pentasaccharide
No binding detected
3 4 3 4
2
3 3 4
2
3 44
4 3 3
2
4 3
2
4 3 336 of 9
R E S EARCH ART I C L EgenomicDNA (donated by J. Atherton,University ofNottingham)with
KODDNApolymerase (Novagen), using the primers specified in table S4,
and cloned into the pOPE101 expression vector (Progen Biotechnik). The
E. coli XL10 Gold strain (Agilent Technologies) was used for both vector
construction and protein expression. Transformed cells were grown in
lysogeny broth [supplemented with ampicillin (100 mg/ml), tetracycline
(12.5mg/ml), and 0.1Mglucose] at 37°Cuntil theOD600 (optical density
at 600 nm) reached ~0.6. Protein expression was induced through the
addition of isopropyl b-D-1-thiogalactopyranoside (IPTG) to a final
concentration of 0.1 mM for 16 hours at 24°C. BabA was harvested
from the periplasmic spaceusinganosmotic shockprocedure asdescribed
in (7). Recombinant BabA, containing amino acids 10 to 527 of mature
BabA in addition to three C-terminal polypeptide tags (6xLys-c-Myc-
6xHis), was purified through immobilized metal ion (nickel) affinity
chromatography and size exclusion chromatography (yield: 1 to 2mg/liter
of bacterial culture) (7).
Selenomethionine-substituted BabA (SeMet BabA)was generated using
the same expression construct and E. coli strain as above. Cells were grown
inM9minimal medium supplemented with thiamine (2 mg/liter), glucose
(4 g/liter), 2mMMgSO4, 0.1mMCaCl2, ampicillin (100 mg/ml), and tetra-
cycline (12.5 mg/ml) at 37°C until the OD600 reached ~0.6. The following
amino acids were added for 15 min before IPTG induction at 24°C for
16 hours: lysine, phenylalanine, and threonine (100mg/liter each) and iso-
leucine, leucine, valine, and DL-selenomethionine (50 mg/liter each). Puri-
ficationwasperformedunder the sameconditions as theunlabeledprotein.
Expression constructs encoding BabA variants containing either
N206A or D233A/S244A substitutions were generated with a Phusion
site-directed mutagenesis kit (Thermo Scientific), using the primers
shown in table S4. Expression and purification was performed under
the same conditions as the wild-type unlabeled protein.
Crystallization
Apo crystals of BabA were obtained by sitting drop vapor diffusion by
mixing equal volumes of protein solution (20 mg/ml) and well solution
[22% polyethylene glycol (PEG) 3350, 0.2 M ammonium acetate, and
0.1 M sodium citrate (pH 5.6)]. Cocrystals of BabA were similarly ob-
tained using a well solution of 22% PEG 3350 and 0.1 M sodium pro-
pionate, sodium cacodylate trihydrate, bis-tris propane (PCTP; pH 6.0).
The complex was formed by adding a fourfold molar excess of Leb an-
tigen hexasaccharide (IsoSep AB) and preincubating at 4°C for 30 min
before dispensing trials. Both crystals appeared after 3 days and con-
tinued to grow for a further 10 days at 20°C.
SeMet crystals were obtained by sitting drop vapor diffusion bymix-
ing 250 nl of protein (20mg/ml), 250 nl of well solution [34% PEG 3350,
0.2 M magnesium acetate, 0.1 M PCTP broad range buffer (pH 6.0)],
and 50 nl of seed stock. The seed stock was prepared by placing three
large apo crystals into a microcentrifuge tube with 50 ml of reservoir
solution. A seed bead was then added and vortexed for 2 min imme-
diately before dispensing plates. Crystals appeared overnight and con-
tinued to grow for a further 5 days at 20°C. Crystals were cryoprotected
by transfer to a well solution including 20% glycerol for 30 s, plunged
into liquid nitrogen, and kept at 100 K during data collection.
Structure solution
Highly redundant Se SADdata were remotely collected at the European
Synchrotron Radiation Facility (ESRF), Grenoble, France (Beamline
ID23-1, DECTRIS Pilatus detector, 100 K) and processed using XDS,
Truncate, and Aimless (35). The anomalous completeness of the dataHage et al. Sci. Adv. 2015;1:e1500315 14 August 2015was 98.3% (87.2% in outer shell), with an anomalousmultiplicity of 12.0
overall (7.0 in outer shell). Anomalous correlation between half-sets was
0.760 in the inner shell and 0.280 overall.
Crank2 (CCP4i) (36–42) was used to solve the structure. The pro-
grams used in pipeline were ShexlC (37), ShelxD (37), Refmac5 (38),
Solomon (39),Multicomb (40), Parrot (41), and Buccaneer (42). ShelxC
found four selenium atoms. Eighty-nine percent of the residues were
built with four gaps in the chain. Coot (43) was used formodel building;
rebuilding of chains across gaps was necessary where they had crossed
to symmetry-related molecules in the initial model. The model was fur-
ther refined as a 1.9-Å data set (Refmac5), although the data were weak
in the outer shell. The residues built in the structure run from Q27 to
L527 (fig. S7) with two loopsmissing from the sequence (betweenA282–
P291 and S402–Q410). The Ramachandran plot showed that 100% of
residues were allowed with 96.04% in the preferred region.
This apomodel was used inmolecular replacement [Phaser (44)] to
solve the structure of the protein complexed with the sugar. X-ray data
for the complex were collected at Diamond Light Source (DLS), Didcot,
UK (Beamline i04, DECTRIS Pilatus detector, 100 K). The sugar was
fitted using Coot (0.8) (43), and refinement was again carried out using
Refmac5. Protein residues Q27 to K528 were modeled in the density,
againwith two gaps in chain (betweenA282–F293 and S402–Q410). Five
of the six sugar units weremodeled; the terminal glucose (Glc6) was not
seen and density for the adjoining galactose (Gal5) was partial. X-ray
data and refinement statistics are shown in table S1.
Isothermal titration calorimetry
Calorimetric measurements were performed at 25°C on a MicroCal
iTC200 System (GE Healthcare) in a buffer containing 20 mM tris-Cl
(pH 7.4) and 300 mMNaCl or 50 mM KH2PO4 (pH 4.5). The sample
cell was filled with protein at a concentration of 0.1 mM and stirred at
1000 rpm until the system reference power was equilibrated to 6 mcal/s.
The injection syringe contained histo-blood group antigen at a concen-
tration of 2 mM, and 19 repeated 2-ml injections were made, allowing
120 s between each titration. These conditions were modified when
studying the BabA:H-1 and BabAN206A variant:Leb interactions, where
the protein and oligosaccharide concentrations were increased to 0.25
and 10mM, respectively, to attain a larger calorimetric response. NITPIC
(45) was used for baseline autodetermination, and calorimetric data were
analyzed by peak integration using ORIGIN 7.0 software. All histo-blood
group antigens (purity >90%) were obtained from Elicityl SA, except Leb,
which was obtained from IsoSep AB.
Sequence analysis
For identification of proteins with structural similarity to BabA, the
apo-BabA PDB file (accession code: 4ZH0) was uploaded onto the Dali
server (21) for an atomic coordinates similarity search within the PDB.
For analysis of strain conservation of the Leb binding site, available
babA gene sequences corresponding to the crown (amino acids 183 to
253 in mature BabA J99) from Leb binding strains identified in (23–25)
were obtained from the EuropeanNucleotide Archive andGenBank. Af-
ter removal of duplicate sequences, CLCMainWorkBench 7.6 (CLCbio)
was used for the multiple sequence alignment (protein) of BabA J99
with 21 H. pylori strains.
To search forDNA sequenceswith similarity to the BabA crown, the
BabA gene fragment corresponding to the crown [that is, complement
(914203–914421) in GenBank accession no. AE001439.1] was submitted
to Nucleotide-BLAST. The nucleotide collection (nr/nt) database was7 of 9
R E S EARCH ART I C L Esearched using megablast, discontiguous, and blastn algorithms. To
search for protein sequences with similarity to the BabA crown, the
BabA protein fragment corresponding to the crown [that is, residues
203 to 273 in GenBank accession no. AAD06409.1] was submitted to
Protein-BLAST. The nonredundant protein sequences (nr) database
was searched using BLAST algorithms optimized for protein-protein,
position-specific iterated, pattern hit initiated, and domain enhanced
lookup time accelerated BLAST.
Statistical analysis
For crystallographic experiments, apo-BabA and BabA:Leb structural
models were built from diffraction data sets collected from single crys-
tals after multiple rounds of iterative refinement. For biophysical anal-
ysis, binding isotherms obtained from ITC were fitted to a nonlinear
least squares curve with Origin 7.0 after multiple iterations until a fixed
minimal c2 value was achieved. An unpaired two-tailed Welch’s t test
was used to determine if the thermodynamic parameters associated with
BabA:Leb binding from three independent experiments at pH 4.5 and
7.4 were significantly different from each other.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/1/7/e1500315/DC1
Materials and Methods
Fig. S1. Glycan symbolic representations of the fucosylated histo-blood group antigens that
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Fig. S3. Alignment of BabA J99 and SabA 26695 protein sequences annotated with secondary
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Fig. S5. Secondary structure and thermal stability of BabA and BabA variants.
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Fig. S7. Rainbow representation of apo-BabA.
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